Trump Medicare Drug Rule Saves Less Than Proposed Amid Bipartisan Pushback
The administration's final rule applies to only four companies while lawmakers warn it hinders patient access to new cancer treatments.
The story so far
2 publishers have covered this in 3 articles since 28 Sept 2026. Fox News Politics published first, on 28 September at 23:46 UTC; STAT followed 47h 29m later. The most recent article, from STAT, appeared on 1 October at 13:26 UTC.
Outlets reporting it: Fox News Politics, STAT.
One prediction market prices this story:
- Yes — the market puts it at 28%, with $31 traded in the last 24 hours, closing 3 Nov 2026. The market resolves to Yes if Donald Trump signs an executive action imposing a tariff of at least 100% on imported generic pharmaceutical drugs before November 3, 2026. Otherwise, it resolves to No. Readers often mistake the linked news story about Medicare drug rules for the required tariff action.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
Markets on this story
- Kalshi Yes 28% +8
Does the market have this right?
Wrong market?
Each tick is a source publishing on this story · 1 more published before price tracking began
Price data
| Time | Chance of yes |
|---|---|
| now | 28% |
| 30 Sept, 23:32 UTC | 28% |
| 29 Sept, 23:20 UTC | 29% |
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Email me when the odds move
How it unfolded
Every source in the order it published, with the odds on Yes at that moment. A dash means the source published before we started tracking prices.
- Fox News PoliticsTrump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law—
- STATTrump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal29%
- STATSTAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more28%▼1 points since the previous source
- Current odds28%
Sources
Every article we clustered into this story. Headlines link to the publisher.
- STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more STAT
- Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal STAT
- Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law Fox News Politics
In this story
- Donald Trump
- CMS